Ampio Pharmaceuticals, Inc. (AMPE)

USD 0.03

(20.42%)

Total Assets Summary of Ampio Pharmaceuticals, Inc.

  • Ampio Pharmaceuticals, Inc.'s latest annual total assets in 2023 was 5.73 Million USD , down -57.79% from previous year.
  • Ampio Pharmaceuticals, Inc.'s latest quarterly total assets in 2023 FY was 5.73 Million USD , down -57.79% from previous quarter.
  • Ampio Pharmaceuticals, Inc. reported annual total assets of 13.58 Million USD in 2022, down -65.0% from previous year.
  • Ampio Pharmaceuticals, Inc. reported annual total assets of 38.82 Million USD in 2021, up 69.7% from previous year.
  • Ampio Pharmaceuticals, Inc. reported quarterly total assets of 5.73 Million USD for 2023 Q4, down -24.98% from previous quarter.
  • Ampio Pharmaceuticals, Inc. reported quarterly total assets of 7.64 Million USD for 2023 Q3, down -16.43% from previous quarter.

Annual Total Assets Chart of Ampio Pharmaceuticals, Inc. (2023 - 2006)

Historical Annual Total Assets of Ampio Pharmaceuticals, Inc. (2023 - 2006)

Year Total Assets Total Assets Growth
2023 5.73 Million USD -57.79%
2022 13.58 Million USD -65.0%
2021 38.82 Million USD 69.7%
2020 22.87 Million USD 63.4%
2019 14 Million USD -0.21%
2018 14.03 Million USD -8.39%
2017 15.31 Million USD 12.64%
2016 13.59 Million USD -73.03%
2015 50.41 Million USD -28.25%
2014 70.26 Million USD 95.09%
2013 36.01 Million USD 39.35%
2012 25.84 Million USD 32.67%
2011 19.48 Million USD 2541.62%
2010 737.52 Thousand USD 2303.85%
2009 30.68 Thousand USD -6.85%
2008 32.93 Thousand USD 3.74%
2007 31.74 Thousand USD 5.29%
2006 30.15 Thousand USD 0.0%

Peer Total Assets Comparison of Ampio Pharmaceuticals, Inc.

Name Total Assets Total Assets Difference
America Great Health 299.12 Thousand USD -1817.567%
Aridis Pharmaceuticals, Inc. 14.69 Million USD 60.966%
Biora Therapeutics, Inc. 31.21 Million USD 81.624%
Bio-Path Holdings, Inc. 3.22 Million USD -78.137%
Better Therapeutics, Inc. 22.94 Million USD 74.999%
Calithera Biosciences, Inc. 28.67 Million USD 79.997%
Comera Life Sciences Holdings, Inc. 3.72 Million USD -53.899%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. 20.54 Million USD 72.079%
Eloxx Pharmaceuticals, Inc. 21.12 Million USD 72.845%
Evelo Biosciences, Inc. 64.44 Million USD 91.099%
Evolutionary Genomics, Inc. 2.35 Million USD -143.7%
Finch Therapeutics Group, Inc. 70.99 Million USD 91.921%
Galera Therapeutics, Inc. 26.14 Million USD 78.057%
Innovation1 Biotech Inc. 75.99 Thousand USD -7448.064%
Kiromic BioPharma, Inc. 12.16 Million USD 52.864%
Molecular Templates, Inc. 35.38 Million USD 83.789%
Navidea Biopharmaceuticals, Inc. 4.37 Million USD -31.21%
NexImmune, Inc. 8.59 Million USD 33.255%
Orgenesis Inc. 14.55 Million USD 60.583%
Panbela Therapeutics, Inc. 11.8 Million USD 51.398%
Point of Care Nano-Technology, Inc. 124.64 Thousand USD -4501.943%
PaxMedica, Inc. Common Stock 5.68 Million USD -0.979%
Scopus BioPharma Inc. 392.26 Thousand USD -1362.277%
Sorrento Therapeutics, Inc. 472.84 Million USD 98.787%
Statera Biopharma, Inc. 21.16 Million USD 72.905%
TRACON Pharmaceuticals, Inc. 10.1 Million USD 43.236%
Trevena, Inc. 40.6 Million USD 85.874%
Vaxxinity, Inc. 44.35 Million USD 87.067%
Vaccinex, Inc. 3.63 Million USD -57.973%
Vicapsys Life Sciences, Inc. 39.65 Thousand USD -14364.394%
Viracta Therapeutics, Inc. 56.69 Million USD 89.882%
ZIVO Bioscience, Inc. 555.71 Thousand USD -932.184%